Growth, tolerance, and DHA and ARA status of healthy term infants receiving formula with two different ARA concentrations: Double-blind, randomized, controlled trial.

Circulating docosahexaenoic acid (DHA) and arachidonic acid (ARA) in total red blood cells (RBC) are considered indicators of fatty acid status. In this study, healthy term infants received study formula through 120 days of age. All study formulas had 17 mg DHA/100 kcal. Investigational formulas had 1) 25 g ARA/100 kcal and no added prebiotic blend (ARA-25; n = 29) or 2) 34 mg ARA/100 kcal and a prebiotic blend (1:1 ratio; 4 g/L) of polydextrose and galactooligosaccharides (PDX/GOS; n = 20). The control formula had 34 mg ARA/100 kcal and no added prebiotic blend (Control: n = 31). Fatty acids in total RBCs and plasma phospholipids (PPLs) at 120 days and buccal epithelial PLs at 14 and 120 days of age were assessed by capillary column gas chromatography. The calculated 90% confidence interval (CI) of each investigational formula relative to the Control for total RBC ARA (ARA-25: 93-105%; PDX/GOS: 96-110%) and total RBC DHA (ARA-25: 95-113%; PDX/GOS: 94-113%) fell within the pre-specified equivalence limit (85-118%), establishing study formula equivalence with respect to ARA and DHA. At day 120, total RBC and buccal epithelia PL ARA (µg/ml) were not significantly correlated (r = 0.041; p = 0.732); correlation in total RBC and buccal epithelia PL DHA was low, albeit significant (r = 0.324; p = 0.006). Consequently, buccal epithelial may not provide a suitable substitute for RBC when assessing fatty acid status and availability. The present RBC data suggest availability of DHA for central nervous system development and function is equivalent among infants receiving formulas that had 34 or 25 mg/100 kcal ARA and 17 mg/100 kcal DHA.

Liquid human milk fortifier significantly improves docosahexaenoic and arachidonic acid status in preterm infants.

We report the fatty acid composition of mother׳s own human milk from one of the largest US cohorts of lactating mothers of preterm infants. Milk fatty acid data were used as a proxy for intake at enrollment in infants (n=150) who received human milk with a powder human milk fortifier (HMF; Control) or liquid HMF [LHMF; provided additional 12mg docosahexaenoic acid (DHA), 20mg arachidonic acid (ARA)/100mL human milk]. Mothers provided milk samples (n=129) and reported maternal DHA consumption (n=128). Infant blood samples were drawn at study completion (Study Day 28). Human milk and infant PPL fatty acids were analyzed using capillary column gas chromatography. DHA and ARA were within ranges previously published for US term and preterm human milk. Compared to Control HMF (providing no DHA or ARA), human milk fortified with LHMF significantly increased infant PPL DHA and ARA and improved preterm infant DHA and ARA status.

In vitro study of Listeria monocytogenes infection to murine primary and human transformed B cells.

Immunity to Listeria monocytogenes is largely mediated by T lymphocytes. Recently, B lymphocytes or their secreted products are implicated to provide immunity against L. monocytogenes infection. To understand whether L. monocytogenes can infect and kill B cells as a possible strategy to initiate an infection, we examined the effects of L. monocytogenes on a human B lymphoma (Ramos RA-1) and mouse primary B cells in vitro. L. monocytogenes infection resulted in significantly (p

Effects of laidlomycin propionate and monensin on glucose utilization and nutrient transport by Streptococcus bovis and Selenomonas ruminantium.

The objective of this study was to compare the effects of laidlomycin propionate and monensin on cell growth, glucose fermentation, and glucose uptake in Streptococcus bovis strain JB1 and Selenomonas ruminantium strain HD4. Experiments were also conducted to compare the effects of both ionophores on sodium-dependent serine transport and cell yield in S. bovis. Batch cultures (500 mL) of each bacterium were grown on 3.6 g/L D-glucose in semidefined medium and treated with either 5 ppm monensin or 2 ppm laidlomycin propionate (n=2). Cell growth was monitored by measuring optical density at 600 nm (OD600). Glucose and L-lactate concentrations were measured using coupled enzyme assays. In S. bovis, both monensin and laidlomycin propionate decreased OD600, glucose utilization, and L-lactate production. Neither ionophore had any effect on glucose utilization by S. ruminantium. [14C]Glucose uptake between 5 and 30 min by both bacteria was not altered by either ionophore. Sodium-dependent [14C]serine uptake by S. bovis was inhibited by monensin but not laidlomycin propionate. When S. bovis was grown in glucose-limited continuous culture (dilution rate=.10 h(-1)) at extracellular pH 6.7, increasing concentrations of both ionophores decreased bacterial yield, and both ionophores were more potent at an extracellular pH of 5.7. However, monensin was a more potent inhibitor than laidlomycin propionate at pH 6.7 and 5.7. Collectively, these results suggest that the ionophore laidlomycin propionate inhibits the Gram-positive bacterium S. bovis in a manner similar to that of monensin, but, at the concentrations used in this study, laidlomycin propionate seems to be less potent than monensin in inhibiting serine uptake and cell yield.

Malate content of forage varieties commonly fed to cattle.

The objective of this study was to determine the concentration of malate in forage varieties at different stages of maturity. Five alfalfa varieties (Alfagraze, Apollo Supreme Cimarron, Crockett, and Magnum III) and three bermudagrass varieties (Coastal, Tifton-78, and Tifton-85) were collected at different stages of maturity. Samples were collected from replicate plots (n = 3) of each alfalfa variety at 9, 18, 28, 35, and 42 d of maturity; bermudagrass hay samples were composited from six bales of each variety from two cuttings staged to be harvested at 27 and 41 d of maturity. Malate was extracted from the samples and quantitated by high performance liquid chromatography using an organic acid column. As maturity increased, the concentration of malate declined in both plant species. Concentrations of malate were numerically higher in two alfalfa varieties (Crockett and Magnum III) at 35 and 42 d of maturity than in all other alfalfa varieties. Concentrations of malate in bermudagrass at 41 d of maturity were lower than concentrations of malate in all alfalfa varieties at 42 d of maturity. Malate declined as maturity increased in the Coastal and Tifton-78 varieties. Because malate stimulates the utilization of lactate by the predominant ruminal bacterium Selenomonas ruminantium, some of the benefits associated with alfalfa in the diets of dairy cattle may be due to the malate in this forage.